Enfusion Investor Presentation Deck
Enfusion at a glance
SCALE
$108MM
Q2 2021 ARR
REACH
635 / 34%
Global clients³/
1H'2021 international revenue %
enfusion
ORGANIC GROWTH
37% / 44%
2019-2020 ARR growth /
2Q'21 YOY ARR growth
MOMENTUM
106
New clients signed in 1H'2021³
PREDICTABLE
98%
Subscription driven
recurring revenue¹
STICKY
0.9%
2020 adjusted revenue churn²
Represents platform subscriptions and managed services revenue for 2020.
2 Excludes involuntary cancellations.
3 As of 30-Jun-2021.
4 Adjusted EBITDA margin is a non-GAAP metric; definitions can be found on slide
38 and reconciliation to nearest GAAP metric can be found on slide 39
CAPTIVE
120%
2020 Net dollar retention²
EFFICIENT
73% / 32%
2020 gross margin /
adjusted EBITDA margin4
PROPRIETARY AND CONFIDENTIAL
Ⓒ2021 ENFUSION. ALL RIGHTS RESERVED.
7View entire presentation